Literature DB >> 29147928

Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.

Andrew D Newton1, Jarrod D Predina2, Leilei Xia2, Robert E Roses2, Giorgos C Karakousis2, Daniel T Dempsey2, Noel N Williams2, John C Kucharczuk2, Sunil Singhal2.   

Abstract

BACKGROUND: In early-stage esophageal adenocarcinoma (EAC), esophagectomy improves staging but also increases mortality compared with endoscopic resection. Our objective was to quantify esophagectomy mortality and lymph node metastasis (LNM) risk in early-stage EAC to improve surgical treatment allocation.
METHODS: We identified National Cancer Database (2004-2014) patients with nonmetastatic, Tis, T1a, or T1b EAC who had primary surgical resection and microscopic examination of at least 15 lymph nodes. Univariate and multivariable logistic regression identified predictors of LNM. Cox regression identified predictors of death. The Kaplan-Meier method predicted overall survival (OS).
RESULTS: In 782 patients, LNM rates were: all patients 13.8%, Tis 0%, T1a 3.6%, T1b 23.4%. Independent predictors of LNM were submucosal invasion, lymphovascular invasion (LVI), decreasing differentiation, and tumor size ≥ 2 cm (P < 0.05). For T1a tumors with poor differentiation or size ≥ 2 cm, LNM rates were 10.2 and 6.7%, respectively; 90-day mortality was 3.1%. The LNM rate in well differentiated T1b tumors < 2 cm was 4.2%; 90-day mortality was 6.0%. Estimated 5-year OS was 80.2% versus 64.4% (T1a vs. T1b). LNM increased risk of death for T1a (hazard ratio [HR] 8.52, 95% confidence interval [CI] 3.13-23.22, P < 0.001) and T1b tumors (HR 2.52, 95% CI 1.59-4.00, P < 0.001).
CONCLUSIONS: In T1a EAC with poor differentiation or size ≥ 2 cm, esophagectomy should be considered, whereas in T1b EAC with low-risk features (well-differentiated T1b EAC < 2 cm without LVI), endoscopic resection may be sufficient. Treatment guidelines for early-stage EAC should include all high-risk tumor features for LNM and stage-specific esophagectomy mortality.

Entities:  

Mesh:

Year:  2017        PMID: 29147928     DOI: 10.1245/s10434-017-6238-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

1.  Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Authors:  Christina Oetzmann von Sochaczewski; Thomas Haist; Michael Pauthner; Markus Mann; Susanne Braun; Christian Ell; Dietmar Lorenz
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

2.  Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer Resections.

Authors:  Feredun Azari; Gregory Kennedy; Elizabeth Bernstein; James Delikatny; John Y K Lee; John Kucharczuk; Phil S Low; Sunil Singhal
Journal:  Mol Imaging Biol       Date:  2021-06-08       Impact factor: 3.488

Review 3.  Advanced Endoscopic Resection Techniques: Endoscopic Submucosal Dissection and Endoscopic Full-Thickness Resection.

Authors:  Phillip S Ge; Hiroyuki Aihara
Journal:  Dig Dis Sci       Date:  2022-03-04       Impact factor: 3.199

4.  The Novel Conduit: Challenges of Esophagectomy After Bariatric Surgery.

Authors:  Michael Jureller; Shankar I Logarajah; Travis Allen Van Meter; Housam Osman; John Jay; Maitham Moslim; Ralph Aye; D Rohan Jeyarajah
Journal:  J Gastrointest Surg       Date:  2022-08-12       Impact factor: 3.267

5.  ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy.

Authors:  Austin D Williams; Anita Mamtani
Journal:  Ann Surg Oncol       Date:  2022-08-16       Impact factor: 4.339

6.  Development and validation of a nomogram for preoperative prediction of lymph node metastasis in pathological T1 esophageal squamous cell carcinoma.

Authors:  Ling Chen; Kaiming Peng; Ziyan Han; Shaobin Yu; Zhixin Huang; Hui Xu; Mingqiang Kang
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

7.  Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis.

Authors:  Amy C Moreno; Ning Zhang; Vivek Verma; Sharon H Giordano; Steven H Lin
Journal:  J Gastrointest Oncol       Date:  2019-02

8.  Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer?

Authors:  Ran Mo; Chen Chen; Liang Pan; Ao Yu; Dongjin Wang; Tao Wang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

9.  Defining low-risk lesions in early-stage esophageal adenocarcinoma.

Authors:  Smita Sihag; Sergio De La Torre; Meier Hsu; Tamar Nobel; Kay See Tan; Hans Gerdes; Pari Shah; Manjit Bains; David R Jones; Daniela Molena
Journal:  J Thorac Cardiovasc Surg       Date:  2020-11-24       Impact factor: 6.439

10.  Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study.

Authors:  Huang-He He; Jun-Hui Fu; Zhe-Xue Hao; He-Fang Wu; Qiang Zhong; Fan Wang; Hang-Hui Liu; Xiang-Sen Gu; Bin Wang; Hao-Da Huang; Zhuo-Yi Li; Jian-Xing He
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.